期刊文献+

IDH1 fine-tunes cap-dependent translation initiation 被引量:2

原文传递
导出
摘要 The metabolic enzyme isocitrate dehydrogenase 1(IDH1)catalyzes the oxidative decarboxylation of isocitrate to a-ketoglutarate(a-KG).Its mutation often leads to aberrant gene expression in cancer.IDH1 was reported to bind thousands of RNA transcripts in a sequence-dependent manner;yet,the functional significance of this RNA-binding activity remains elusive.Here,we report that IDH1 promotes mRNA translation via direct associations with polysome mRNA and translation machinery.Comprehensive proteomic analysis in embryonic stem cells(ESCs)revealed strikingenrichmentof ribosomal proteins and translation regulators in IDH1-bound protein interactomes.We performed ribosomal profiling and analyzed mRNA transcripts that are associated with actively translating polysomes.Interestingly,knockout of IDH1 in ESCs led to significant downregulation of polysome-bound mRNA in IDH1 targets and subtle upregulation of ribosome densities at the start codon,indicating inefficient translation initiation upon loss of IDH1.Tethering IDH1 to a luciferase mRNA via the MS2-MBP system promotes luciferase translation,independently of the catalytic activity of IDH1.Intriguingly,IDH1 fails to enhance luciferase translation driven by an internal ribosome entry site.Together,these results reveal an unforeseen role of IDH1 in fine-tuning cap-dependent translation via the initiation step.
出处 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2019年第10期816-828,共13页 分子细胞生物学报(英文版)
基金 This work was supported in part by the National Natural Science Foundation of China(31471219 and 31630095) the National Basic Research Program of China(2017YFA0504204) the Center for Life Sciences at Tsinghua University.
  • 相关文献

参考文献2

二级参考文献34

  • 1Balss J, Meyer J, Mueller W, Korshtmov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropatho12008; 116:597-602.
  • 2Bleeker FE, Lamba S, Leenstra S, et al. IDH1 mutations at residue p.R132 (1DH1R~32) occur frequently in high-grade gliomas but not in other solid amaors. Hum Mutat 2009; 30:7- 11.
  • 3Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. NEnglJMed2009; 360:765-773.
  • 4Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009; 174:1149-1153.
  • 5Ichimura K, Pearson DM, Kocialkowski S, et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 2009; 11:341- 347.
  • 6Hartmarm C, Meyer J, Balss J, et al. Type and frequency of IDHI and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009; 118:469-474.
  • 7Hayden JT, Fruhwald MC, Hasselblatt M, Ellison DW, Bailey S, Clifford SC. Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children. Cell Cycle 2009; 8:1806-1807.
  • 8Verhaak RGW, Hoadley KA, Purdom E, et al. Intergrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98-110.
  • 9Mardis ER, Ding L, Dooling D J, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl.l Med 2009; 361:1058-1066.
  • 10Kang MR, Kim MS, Oh JE, et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 2009; 125:353-355.

共引文献84

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部